Annual CFF
$274.40 M
+$47.55 M+20.96%
31 December 2023
Summary:
Pliant Therapeutics annual cash flow from financing activities is currently $274.40 million, with the most recent change of +$47.55 million (+20.96%) on 31 December 2023. During the last 3 years, it has risen by +$61.19 million (+28.70%). PLRX annual CFF is now at all-time high.PLRX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
$543.00 K
-$141.00 K-20.61%
30 September 2024
Summary:
Pliant Therapeutics quarterly cash flow from financing activities is currently $543.00 thousand, with the most recent change of -$141.00 thousand (-20.61%) on 30 September 2024. Over the past year, it has dropped by -$156.00 thousand (-22.32%). PLRX quarterly CFF is now -99.80% below its all-time high of $273.33 million, reached on 31 March 2023.PLRX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$23.23 M
-$156.00 K-0.67%
30 September 2024
Summary:
Pliant Therapeutics TTM cash flow from financing activities is currently $23.23 million, with the most recent change of -$156.00 thousand (-0.67%) on 30 September 2024. Over the past year, it has dropped by -$251.24 million (-91.53%). PLRX TTM CFF is now -95.36% below its all-time high of $500.33 million, reached on 31 March 2023.PLRX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PLRX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.0% | -22.3% | -91.5% |
| 3 y3 years | +28.7% | +20.9% | +933.5% |
| 5 y5 years | +214.2% | +237.8% | +1898.3% |
PLRX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -99.8% | +454.9% | -95.4% | +2214.1% |
| 5 y | 5 years | at high | >+9999.0% | -99.8% | +123.0% | -95.4% | +1898.3% |
| alltime | all time | at high | >+9999.0% | -99.8% | +123.0% | -95.4% | +1898.3% |
Pliant Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $543.00 K(-20.6%) | $23.23 M(-0.7%) |
| June 2024 | - | $684.00 K(-96.9%) | $23.39 M(+2.3%) |
| Mar 2024 | - | $21.79 M(+9848.9%) | $22.87 M(-91.7%) |
| Dec 2023 | $274.40 M(+21.0%) | $219.00 K(-68.7%) | $274.40 M(-0.0%) |
| Sept 2023 | - | $699.00 K(+334.2%) | $274.47 M(-44.0%) |
| June 2023 | - | $161.00 K(-99.9%) | $490.07 M(-2.1%) |
| Mar 2023 | - | $273.33 M(>+9900.0%) | $500.33 M(+120.6%) |
| Dec 2022 | $226.85 M(+8877.2%) | $284.00 K(-99.9%) | $226.85 M(-0.1%) |
| Sept 2022 | - | $216.30 M(+1974.6%) | $227.09 M(+1920.7%) |
| June 2022 | - | $10.43 M(-6914.4%) | $11.24 M(+1019.3%) |
| Mar 2022 | - | -$153.00 K(-129.7%) | $1.00 M(-60.3%) |
| Dec 2021 | $2.53 M | $516.00 K(+14.9%) | $2.53 M(+12.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $449.00 K(+133.9%) | $2.25 M(-497.2%) |
| June 2021 | - | $192.00 K(-86.0%) | -$566.00 K(-100.3%) |
| Mar 2021 | - | $1.37 M(+478.1%) | $162.88 M(-23.6%) |
| Dec 2020 | $213.21 M(+368.2%) | $237.00 K(-110.0%) | $213.21 M(-17.9%) |
| Sept 2020 | - | -$2.37 M(-101.4%) | $259.81 M(-0.8%) |
| June 2020 | - | $163.64 M(+216.5%) | $261.78 M(+168.9%) |
| Mar 2020 | - | $51.70 M(+10.4%) | $97.37 M(+113.8%) |
| Dec 2019 | $45.54 M(-47.9%) | $46.83 M(<-9900.0%) | $45.54 M(-3624.7%) |
| Sept 2019 | - | -$394.00 K(-48.9%) | -$1.29 M(+43.9%) |
| June 2019 | - | -$771.00 K(+507.1%) | -$898.00 K(+607.1%) |
| Mar 2019 | - | -$127.00 K | -$127.00 K |
| Dec 2018 | $87.35 M | - | - |
FAQ
- What is Pliant Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Pliant Therapeutics?
- What is Pliant Therapeutics annual CFF year-on-year change?
- What is Pliant Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Pliant Therapeutics?
- What is Pliant Therapeutics quarterly CFF year-on-year change?
- What is Pliant Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Pliant Therapeutics?
- What is Pliant Therapeutics TTM CFF year-on-year change?
What is Pliant Therapeutics annual cash flow from financing activities?
The current annual CFF of PLRX is $274.40 M
What is the all time high annual CFF for Pliant Therapeutics?
Pliant Therapeutics all-time high annual cash flow from financing activities is $274.40 M
What is Pliant Therapeutics annual CFF year-on-year change?
Over the past year, PLRX annual cash flow from financing activities has changed by +$47.55 M (+20.96%)
What is Pliant Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of PLRX is $543.00 K
What is the all time high quarterly CFF for Pliant Therapeutics?
Pliant Therapeutics all-time high quarterly cash flow from financing activities is $273.33 M
What is Pliant Therapeutics quarterly CFF year-on-year change?
Over the past year, PLRX quarterly cash flow from financing activities has changed by -$156.00 K (-22.32%)
What is Pliant Therapeutics TTM cash flow from financing activities?
The current TTM CFF of PLRX is $23.23 M
What is the all time high TTM CFF for Pliant Therapeutics?
Pliant Therapeutics all-time high TTM cash flow from financing activities is $500.33 M
What is Pliant Therapeutics TTM CFF year-on-year change?
Over the past year, PLRX TTM cash flow from financing activities has changed by -$251.24 M (-91.53%)